Cargando…

Extracellular matrix composition defines an ultra-high-risk group of neuroblastoma within the high-risk patient cohort

BACKGROUND: Although survival for neuroblastoma patients has dramatically improved in recent years, a substantial number of children in the high-risk subgroup still die. METHODS: We aimed to define a subgroup of ultra-high-risk patients from within the high-risk cohort. We used advanced morphometric...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tadeo, Irene, Berbegall, Ana P, Castel, Victoria, García-Miguel, Purificación, Callaghan, Robert, Påhlman, Sven, Navarro, Samuel, Noguera, Rosa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4985353/ https://www.ncbi.nlm.nih.gov/pubmed/27415013 http://dx.doi.org/10.1038/bjc.2016.210

Ejemplares similares

Intra-Tumour Genetic Heterogeneity and Prognosis in High-Risk Neuroblastoma
por: López-Carrasco, Amparo, et al.
Publicado: (2021)

Imbalance between genomic gain and loss identifies high-risk neuroblastoma patients with worse outcomes
por: Fernández-Blanco, Beatriz, et al.
Publicado: (2020)

Augmented expression of MYC and/or MYCN protein defines highly aggressive MYC-driven neuroblastoma: a Children's Oncology Group study
por: Wang, L L, et al.
Publicado: (2015)

International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee
por: Ambros, P F, et al.
Publicado: (2009)

Neuroblastoma after Childhood: Prognostic Relevance of Segmental Chromosome Aberrations, ATRX Protein Status, and Immune Cell Infiltration()
por: Berbegall, Ana P., et al.
Publicado: (2014)

Genetic Instability and Intratumoral Heterogeneity in Neuroblastoma with MYCN Amplification Plus 11q Deletion
por: Villamón, Eva, et al.
Publicado: (2013)

Biotensegrity of the Extracellular Matrix: Physiology, Dynamic Mechanical Balance, and Implications in Oncology and Mechanotherapy
por: Tadeo, Irene, et al.
Publicado: (2014)

Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the International Neuroblastoma Risk Group Task Force
por: Beiske, K, et al.
Publicado: (2009)

Impact of extracellular matrix stiffness on genomic heterogeneity in MYCN-amplified neuroblastoma cell line
por: López-Carrasco, Amparo, et al.
Publicado: (2020)

High-risk HPV type-specific clearance rates in cervical screening
por: Bulkmans, N W J, et al.
Publicado: (2007)

Neuroblastoma patient-derived orthotopic xenografts retain metastatic patterns and geno- and phenotypes of patient tumours
por: Braekeveldt, Noémie, et al.
Publicado: (2015)

High viral loads of human papillomavirus predict risk of invasive cervical carcinoma
por: Moberg, M, et al.
Publicado: (2005)

Lymph microvascularization as a prognostic indicator in neuroblastoma
por: Tadeo, Irene, et al.
Publicado: (2018)

Human papillomavirus in high- and low-risk areas of oesophageal squamous cell carcinoma in China
por: Shuyama, K, et al.
Publicado: (2007)

Short-time repeat high-risk HPV testing by self-sampling for screening of cervical cancer
por: Gyllensten, U, et al.
Publicado: (2011)

pHH3 and survivin are co-expressed in high-risk endometrial cancer and are prognostic relevant
por: Brunner, A, et al.
Publicado: (2012)

Identification of high-risk patients with clear cell renal cell carcinoma based on interphase-FISH
por: Sanjmyatav, J, et al.
Publicado: (2014)

Tenascin-C and fibronectin expression divide early stage tongue cancer into low- and high-risk groups
por: Sundquist, Elias, et al.
Publicado: (2017)

Telomerase activity as an adjunct to high-risk human papillomavirus types 16 and 18 and cytology screening in cervical cancer
por: Kailash, U, et al.
Publicado: (2006)

High-risk human papillomavirus in non-melanoma skin lesions from renal allograft recipients and immunocompetent patients
por: Reuschenbach, M, et al.
Publicado: (2011)

Effects of the histone deacetylase inhibitor valproic acid on Notch signalling in human neuroblastoma cells
por: Stockhausen, M-T, et al.
Publicado: (2005)

Quiescence and γH2AX in neuroblastoma are regulated by ouabain/Na,K-ATPase
por: Hiyoshi, H, et al.
Publicado: (2012)

Prognostic analysis of tumour angiogenesis, determined by microvessel density and expression of vascular endothelial growth factor, in high-risk primary breast cancer patients treated with high-dose chemotherapy
por: Nieto, Y, et al.
Publicado: (2007)

Type distribution, viral load and integration status of high-risk human papillomaviruses in pre-stages of cervical cancer (CIN)
por: Andersson, S, et al.
Publicado: (2005)

Chronic lymphocytic leukaemia patients have a high risk of Merkel-cell polyomavirus DNA-positive Merkel-cell carcinoma
por: Koljonen, V, et al.
Publicado: (2009)

Growth differentiation factor 15: a prognostic marker for recurrence in colorectal cancer
por: Wallin, U, et al.
Publicado: (2011)

MYCN gene amplification is a powerful prognostic factor even in infantile neuroblastoma detected by mass screening
por: Iehara, T, et al.
Publicado: (2006)

Identification of the high-risk group for metastasis of gastric cancer cases by vascular endothelial growth factor receptor-1 overexpression in peripheral blood
por: Kosaka, Y, et al.
Publicado: (2007)

Tyrosinase-related protein 1 mRNA expression in lymph node metastases predicts overall survival in high-risk melanoma patients
por: El Hajj, P, et al.
Publicado: (2013)

Human papillomavirus genotype distribution and cervical squamous intraepithelial lesions among high-risk women with and without HIV-1 infection in Burkina Faso
por: Didelot-Rousseau, M-N, et al.
Publicado: (2006)

Reproductive factors and subtypes of breast cancer defined by hormone receptor and histology
por: Ursin, G, et al.
Publicado: (2005)

Study of matrix metalloproteinases and their inhibitors in prostate cancer
por: Escaff, S, et al.
Publicado: (2010)

Inhibition of Akt sensitises neuroblastoma cells to gold(III) porphyrin 1a, a novel antitumour drug induced apoptosis and growth inhibition
por: Li, W, et al.
Publicado: (2009)

Expression of miR-487b and miR-410 encoded by 14q32.31 locus is a prognostic marker in neuroblastoma
por: Gattolliat, C-H, et al.
Publicado: (2011)

Nuclear CSPP1 expression defined subtypes of basal-like breast cancer
por: Sternemalm, J, et al.
Publicado: (2014)

Comprehensive profiling and localisation of the matrix metalloproteinases in urothelial carcinoma
por: Wallard, M J, et al.
Publicado: (2006)

Circulating tumour markers can define patients with normal colons, benign polyps, and cancers
por: Mead, R, et al.
Publicado: (2011)

Vascular tube formation on matrix metalloproteinase-1-damaged collagen
por: Varani, J, et al.
Publicado: (2008)

Integrative discovery of treatments for high-risk neuroblastoma
por: Almstedt, Elin, et al.
Publicado: (2020)

Matrix metalloproteinase-2 is a consistent prognostic factor in gastric cancer
por: Kubben, F J G M, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_g9obvcatg37pllm041li57t7fm